Oestrogen receptor α (ERα) non-nuclear signalling confers protection against heart failure remodelling, involving myocardial cyclic guanosine monophosphate (cGMP)–cGMP-dependent protein kinase G (PKG) activation; however, its tissue-specific role remains elusive. This evidence concerns the gene PRKG1 and heart failure.